JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M705329200 on September 26, 2007

J. Biol. Chem., Vol. 282, Issue 48, 35113-35124, November 30, 2007
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Supplemental Data
Right arrow All Versions of this Article:
282/48/35113    most recent
M705329200v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Srivastava, A. K.
Right arrow Articles by Kumar, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Srivastava, A. K.
Right arrow Articles by Kumar, A.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Tumor Necrosis Factor-{alpha} Augments Matrix Metalloproteinase-9 Production in Skeletal Muscle Cells through the Activation of Transforming Growth Factor-β-activated Kinase 1 (TAK1)-dependent Signaling Pathway*Formula

Apurva K. Srivastava{ddagger}§, Xuezhong Qin{ddagger}§, Nia Wedhas{ddagger}, Marc Arnush{ddagger}, Thomas A. Linkhart{ddagger}§, Robert B. Chadwick{ddagger}§, and Ashok Kumar{ddagger}§1

From the {ddagger}Jerry L. Pettis Memorial Veterans Affairs Medical Center, Loma Linda, California 92357, §Loma Linda University School of Medicine, Loma Linda, California 92350, and the Department of Anatomical Sciences and Neurobiology, University of Louisville School of Medicine, Louisville, Kentucky 40202

We have investigated the effect of tumor necrosis factor-{alpha} (TNF-{alpha}) on the production of extracellular matrix-degrading proteases in skeletal muscles. Using microarray, quantitative PCR, Western blotting, and zymography, we found that TNF-{alpha} drastically increases the production of matrix metalloproteinase (MMP)-9 from C2C12 myotubes. In vivo administration of TNF-{alpha} in mice increased the transcript level of MMP-9 in skeletal muscle tissues. Although TNF-{alpha} activated all the three MAPKs (i.e. ERK1/2, JNK, and p38), inhibition of ERK1/2 or p38 but not JNK blunted the TNF-{alpha}-induced production of MMP-9 from myotubes. Inhibition of Akt also inhibited the TNF-{alpha}-induced production of MMP-9. TNF-{alpha} increased the activation of transcription factors NF-{kappa}B and AP-1 but not SP-1 in myotubes. Overexpression of a dominant negative inhibitor of NF-{kappa}B or AP-1 blocked the TNF-{alpha}-induced expression of MMP-9 in myotubes. Similarly, point mutations in AP-1- or NF-{kappa}B-binding sites in MMP-9 promoter inhibited the TNF-{alpha}-induced expression of a reporter gene. TNF-{alpha} increased the activity of transforming growth factor-β-activating kinase-1 (TAK1). Furthermore, overexpression of a dominant negative mutant of TAK1 blocked the TNF-{alpha}-induced expression of MMP-9 and activation of NF-{kappa}B and AP-1. Our results also suggest that TNF-{alpha} induces MMP-9 expression in muscle cells through the recruitment of TRAF-2, Fas-associated protein with death domain, and TNF receptor-associated protein with death domain but not NIK or TRAF-6 proteins. We conclude that TAK1-mediated pathways are involved in TNF-{alpha}-induced MMP-9 production in skeletal muscle cells.


Received for publication, June 28, 2007 , and in revised form, September 4, 2007.

* This work was supported by National Institute of Health Grant RO1 AG129623 (to A. K.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

Formula The on-line version of this article (available at http://www.jbc.org) contains supplemental Table 1S, Fig. 1S, and an additional reference.

1 To whom correspondence should be addressed: Dept. of Anatomical Sciences and Neurobiology, University of Louisville School of Medicine, 500 S. Preston St., Louisville, KY 40202. Tel.: 502-852-1133; Fax: 502-852-6228; E-mail: ashok.kumar{at}louisville.edu.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?





HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2007 by the American Society for Biochemistry and Molecular Biology.